In a USC Keck School of Medicine press release, senior author Susanne Hempel, PhD, said, "The main message is, if your doctor ...

Antiviral medications nirmatrelvir/ritonavir (Paxlovid ... persistent SARS-CoV-2 virus may continue to replicate in the body ...

Research from the Keck School of Medicine has found that COVID-19 therapies cause few serious side effects, based on an ...

The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral ... authorized by the FDA due to their lack ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

Federal drug regulators have missed the deadline for making a key decision regarding a Covid-19 vaccine from Novavax, days after the Food and Drug Administration’s vaccine chief was pushed out. The ...

(CNN) — The US Food and Drug Administration has delayed granting full approval of Novavax ... alternative to mRNA Covid-19 vaccines for the US,” Novavax said. The FDA’s press office ...